Stockreport

Sionna Therapeutics to Participate in Upcoming November Investor Conferences

Sionna Therapeutics, Inc.  (SION) 
PDF WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize th [Read more]